| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5648093 | JANSSEN PHARMA | Pharmaceutical and other dosage forms |
Jul, 2014
(9 years ago) | |
Propulsid Quicksolv is owned by Janssen Pharma.
Propulsid Quicksolv contains Cisapride Monohydrate.
Propulsid Quicksolv has a total of 1 drug patent out of which 1 drug patent has expired.
Expired drug patents of Propulsid Quicksolv are:
- US5648093
Propulsid Quicksolv was authorised for market use on 07 November, 1997.
Propulsid Quicksolv is available in tablet, orally disintegrating;oral dosage forms.
The generics of Propulsid Quicksolv are possible to be released after 15 July, 2014.
Drugs and Companies using CISAPRIDE MONOHYDRATE ingredient
Market Authorisation Date: 07 November, 1997
Treatment: NA
Dosage: TABLET, ORALLY DISINTEGRATING;ORAL
More Information on Dosage
PROPULSID QUICKSOLV family patents
